Market Indices
Sector Heatmap
PYXS — Pyxis Oncology, Inc. Common Stock
NasdaqPyxis Oncology, Inc. Common Stock
- O
- 2.02
- H
- 2.09
- L
- 2.00
- V
- 951.89K
PYXS — Latest News & Headlines
20 StoriesPYXS Stock Price, Quote & Chart - ChartMill
PYXS Stock Price, Quote & Chart ChartMill
Latham Advises on Pyxis Oncology’s Up to US$282.6 Million Public Offering - Latham & Watkins LLP
Latham Advises on Pyxis Oncology’s Up to US$282.6 Million Public Offering Latham & Watkins LLP
Pyxis Oncology stock falls on public offering announcement - Yahoo Finance UK
Pyxis Oncology stock falls on public offering announcement Yahoo Finance UK
A 10% owner buys $2.90 share-and-warrant packages in Pyxis Oncology (PYXS). - Stock Titan
A 10% owner buys $2.90 share-and-warrant packages in Pyxis Oncology (PYXS). Stock Titan
Pyxis Oncology shares slide after pricing $110M registered public offering - TradingView
Pyxis Oncology shares slide after pricing $110M registered public offering TradingView
Pyxis Oncology Announces Proposed Registered Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants - Quiver Quantitative
Pyxis Oncology Announces Proposed Registered Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants Quiver Quantitative
Biggest stock movers Wednesday: BA, PYXS, NOC, and more (NOC:NYSE) - Seeking Alpha
Biggest stock movers Wednesday: BA, PYXS, NOC, and more (NOC:NYSE) Seeking Alpha
Pyxis Oncology Prices Public Offering of Common Stock, Warrants - Yahoo Finance
Pyxis Oncology Prices Public Offering of Common Stock, Warrants Yahoo Finance
Pyxis Oncology Prices Public Offering of Common Stock, Warrants - marketscreener.com
Pyxis Oncology Prices Public Offering of Common Stock, Warrants marketscreener.com
An ownership cap restricts warrant exercise for a Pyxis Oncology (PYXS) investor. - Stock Titan
An ownership cap restricts warrant exercise for a Pyxis Oncology (PYXS) investor. Stock Titan
Pyxis Oncology: Better Runway Is Bullish For MICVO’s Remaining R&D (NASDAQ:PYXS) - Seeking Alpha
Pyxis Oncology: Better Runway Is Bullish For MICVO’s Remaining R&D (NASDAQ:PYXS) Seeking Alpha
Pyxis Oncology Closes $110 Million Public Offering to Advance MICVO Clinical Development - Quiver Quantitative
Pyxis Oncology Closes $110 Million Public Offering to Advance MICVO Clinical Development Quiver Quantitative
Pyxis Oncology launches offering for phase 3 cancer trial; stock tumbles - TradingView
Pyxis Oncology launches offering for phase 3 cancer trial; stock tumbles TradingView
Pyxis Oncology launches public offering of stock and warrants By Investing.com - Investing.com Nigeria
Pyxis Oncology launches public offering of stock and warrants By Investing.com Investing.com Nigeria
A passive holder reports over 5% of Pyxis Oncology (PYXS), with some warrants excluded. - Stock Titan
A passive holder reports over 5% of Pyxis Oncology (PYXS), with some warrants excluded. Stock Titan
Pyxis Oncology closes $110 million public offering By Investing.com - Investing.com Nigeria
Pyxis Oncology closes $110 million public offering By Investing.com Investing.com Nigeria
PYXS 8-K & SEC Filings - Yahoo Finance
PYXS 8-K & SEC Filings Yahoo Finance
Pyxis Oncology (PYXS) Slips 2.28% to $2.14 as Shares Test Lower End of Recent Range - Ichimoku Cloud - https://www.dars.gov.et/
Pyxis Oncology (PYXS) Slips 2.28% to $2.14 as Shares Test Lower End of Recent Range - Ichimoku Cloud https://www.dars.gov.et/
Pyxis Oncology stock fell 9.82 percent on October 6 after financing - AD HOC NEWS
Pyxis Oncology stock fell 9.82 percent on October 6 after financing AD HOC NEWS
Pyxis Oncology prices $110 million public offering By Investing.com - Investing.com UK
Pyxis Oncology prices $110 million public offering By Investing.com Investing.com UK